The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates

Cell - Tập 85 Số 7 - Trang 1135-1148 - 1996
Hyeryun Choe1, Michael Farzan1, Ying Sun1, Nancy Sullivan2,1, Barrett J. Rollins3, Paul Ponath4, Lijun Wu4, Charles R. Mackay4, Gregory J. LaRosa4, Walter Newman4, Norma P. Gerard5, Craig Gérard5, Joseph Sodroski2,1
1Division of Human Retrovirology, Dana-Farber Cancer Institute, Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115, USA
2Department of Cancer Biology, Harvard School of Public Health, Boston, Massachusetts 02115, USA
3Department of Medicine, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA
4LeukoSite, Inc., 215 First Street, Cambridge, Massachusetts 02142, USA
5Perlmutter Laboratory, Children's Hospital, Department of Medicine, Department of Pediatrics, Beth Israel Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Alizon, 1986, Genetic variability of the AIDS virus, Cell, 46, 63, 10.1016/0092-8674(86)90860-3

Ashorn, 1990, Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cells, J. Virol., 64, 2149, 10.1128/JVI.64.5.2149-2156.1990

Åsjö, 1986, Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection, Lancet, 2, 660, 10.1016/S0140-6736(86)90169-8

Baggiolini, 1994, Interleukin-8 and related chemotactic cytokines—CXC and CC chemokines, Adv. Immunol., 55, 97, 10.1016/S0065-2776(08)60509-X

Barak, 1994, A highly conserved tyrosine residue in G protein–coupled receptors is required for agonist-mediated β2-adrenergic receptor sequestration, J. Biol. Chem., 269, 2790, 10.1016/S0021-9258(17)42012-6

Barré-Sinoussi, 1983, Isolation of a T-lymphocyte retrovirus from a patient at risk for acquired immunodeficiency syndrome (AIDS), Science, 220, 868, 10.1126/science.6189183

Bergeron, 1992, Target cell-specific determinants of membrane fusion within the human immunodeficiency virus type 1 gp120 third variable region and gp41 amino terminus, J. Virol., 66, 2389, 10.1128/JVI.66.4.2389-2397.1992

Birkenbach, 1993, Epstein-Barr virus-induced genes, J. Virol., 67, 2209, 10.1128/JVI.67.4.2209-2220.1993

Bou-Habib, 1994, Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization, J. Virol., 68, 6006, 10.1128/JVI.68.9.6006-6013.1994

Brand, 1995, Determinants of human immunodeficiency virus type 1 entry in the CDR2 loop of the CD4 glycoprotein, J. Virol., 69, 166, 10.1128/JVI.69.1.166-171.1995

Broder, 1993, The block to HIV-1 envelope glycoprotein-mediated membrane fusion in animal cells expressing human CD4 can be overcome by a human cell component(s), Virology, 193, 483, 10.1006/viro.1993.1151

Broder, 1995, Fusogenic selectivity of the envelope glycoprotein is a major determinant of human immunodeficiency virus type 1 tropism for CD4+ T cell lines vs. primary macrophages, Proc. Natl. Acad. Sci. USA, 92, 9004, 10.1073/pnas.92.19.9004

Burton, 1994, Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody, Science, 266, 1024, 10.1126/science.7973652

Carrillo, 1993, Identification of HIV-1 determinants for T lymphoid cell line infection, Virology, 197, 817, 10.1006/viro.1993.1664

Charo, 1994, Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails, Proc. Natl. Acad. Sci. USA, 91, 2752, 10.1073/pnas.91.7.2752

Chaudhuri, 1993, Cloning of gpD protein cDNA, the major subunit of the Duffy blood group system and the receptor for the Plasmodium vivax malaria parasite, Proc. Natl. Acad. Sci. USA, 29, 10793, 10.1073/pnas.90.22.10793

Cheng-Mayer, 1988, Biologic features of HIV-1 that correlate with virulence in the host, Science, 240, 80, 10.1126/science.2832945

Cheng-Mayer, 1990, Viral determinants of human immunodeficiency virus type 1 T-cell or macrophage tropism, cytopathogenicity, and CD4 antigen modulation, J. Virol., 64, 4390, 10.1128/JVI.64.9.4390-4398.1990

Chesebro, 1990, Failure of human immunodeficiency virus entry and infection in CD4-positive human brain and skin cells, J. Virol., 64, 215, 10.1128/JVI.64.1.215-221.1990

Chesebro, 1991, Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophages, J. Virol., 65, 5782, 10.1128/JVI.65.11.5782-5789.1991

Chesebro, 1992, Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates, J. Virol., 66, 6547, 10.1128/JVI.66.11.6547-6554.1992

Clapham, 1991, Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by simian immunodeficiency virus, Virology, 181, 703, 10.1016/0042-6822(91)90904-P

Cocchi, 1995, Identification of RANTES, MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells, Science, 270, 1811, 10.1126/science.270.5243.1811

Collman, 1992, An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1, J. Virol., 66, 7517, 10.1128/JVI.66.12.7517-7521.1992

Connor, 1994, Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression, J. Virol., 68, 4400, 10.1128/JVI.68.7.4400-4408.1994

Connor, 1994, Transmission and pathogenesis of human immunodeficiency virus type 1, AIDS Res. Hum. Retro., 10, 321, 10.1089/aid.1994.10.321

Connor, 1993, Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals, J. Virol., 67, 1772, 10.1128/JVI.67.4.1772-1777.1993

Cullen, 1989, Use of eukaryotic expression technology in the functional analysis of cloned genes, Methods Enzymol., 152, 64

Cundell, 1995, Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor, Nature, 377, 435, 10.1038/377435a0

Dalgleish, 1984, The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus, Nature, 312, 763, 10.1038/312763a0

Daugherty, 1996, Cloning, expression, and characterization of the human eosinophil eotaxin receptor, J. Exp. Med., 183, 2349, 10.1084/jem.183.5.2349

Dragic, 1992, Complementation of murine cells for human immunodeficiency virus envelope/CD4-mediated fusion in human/murine heterokaryons, J. Virol., 66, 4794, 10.1128/JVI.66.8.4794-4802.1992

Fauci, 1984, Acquired immunodeficiency syndrome, Ann. Int. Med., 100, 92, 10.7326/0003-4819-100-1-92

Federsppiel, 1993, Molecular cloning of the cDNA and chromosomal localization of the gene for a putative seven-transmembrane segment (7-TMS) receptor isolated from human spleen, Genomics, 16, 707, 10.1006/geno.1993.1251

Feng, 1996, HIV-1 entry cofactor, Science, 272, 872, 10.1126/science.272.5263.872

Fenyö, 1988, Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates, J. Virol., 62, 4414, 10.1128/JVI.62.11.4414-4419.1988

Fisher, 1985, A molecular clone of HTLV-III with biologic activity, Nature, 316, 262, 10.1038/316262a0

Freed, 1991, Identification of the principal neutralizing determinant of human immunodeficiency virus type 1 as a fusion domain, J. Virol., 65, 190, 10.1128/JVI.65.1.190-194.1991

Freedman, 1991, Human immunodeficiency virus infection of eosinophils in human bone marrow cultures, J. Exp. Med., 174, 1661, 10.1084/jem.174.6.1661

Gallo, 1984, Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS, Science, 224, 500, 10.1126/science.6200936

Gao, 1996, Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G, J. Virol., 70, 1651, 10.1128/JVI.70.3.1651-1667.1996

Gartner, 1986, The role of mononuclear phagocytes in HTLV-III/LAV infection, Science, 233, 215, 10.1126/science.3014648

Gendelman, 1988, Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes, J. Exp. Med., 167, 1428, 10.1084/jem.167.4.1428

Gerard, 1994, The pro-inflammatory seven-transmembrane-segment receptors of the leukocyte, Curr. Opin. Immunol., 6, 140, 10.1016/0952-7915(94)90045-0

Goudsmit, 1988, Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees, Proc. Natl. Acad. Sci. USA, 85, 4478, 10.1073/pnas.85.12.4478

Grimaila, 1992, Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralization, J. Virol., 66, 1875, 10.1128/JVI.66.4.1875-1883.1992

Helseth, 1990, Rapid complementation assays measuring replicative potential of HIV-1 envelope glycoprotein mutants, J. Virol., 64, 2416, 10.1128/JVI.64.5.2416-2420.1990

Horuk, 1993, The erythrocyte chemokine receptor is a receptor for the malarial parasite Plasmodium vivax, Science, 261, 1182, 10.1126/science.7689250

Horuk, 1994, Molecular properties of the chemokine receptor family, Trends Pharmacol. Sci., 15, 159, 10.1016/0165-6147(94)90077-9

Hwang, 1991, Identification of the V3 loop as the primary determinant of cell tropism in HIV-1, Science, 253, 71, 10.1126/science.1905842

Ivanoff, 1991, Alteration of HIV-1 infectivity and neutralization by a single amino acid replacement in the V3 loop domain, AIDS Res. Hum. Retroviruses, 7, 595, 10.1089/aid.1991.7.595

Javaherian, 1989, Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein, Proc. Natl. Acad. Sci. USA, 86, 6768, 10.1073/pnas.86.17.6768

Jazin, 1993, A proposed bovine neuropeptide Y (NPY) receptor cDNA clone, or its human homologue, confers neither NPY binding sites nor NPY responsiveness on transfected cells, Regulatory Peptides, 47, 247, 10.1016/0167-0115(93)90392-L

Jose, 1994, Eotaxin, J. Exp. Med., 179, 881, 10.1084/jem.179.3.881

Karlsson, 1996, Increased envelope spike density and stability are not required for the neutralization resistance of primary human immunodeficiency viruses, J. Virol., in press., 10.1128/JVI.70.9.6136-6142.1996

Kitaura, 1996, Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3, J. Biol. Chem., 271, 7725, 10.1074/jbc.271.13.7725

Klatzmann, 1984, T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV, Nature (London), 312, 767, 10.1038/312767a0

Koenig, 1986, Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy, Science, 233, 1089, 10.1126/science.3016903

Kowalski, 1987, Functional regions of the human immunodeficiency virus envelope glycoproteins, Science, 237, 1351, 10.1126/science.3629244

Kunz, 1991, The human leukocyte platelet activating factor receptor, J. Biol. Chem., 267, 9101, 10.1016/S0021-9258(19)50394-5

Landau, 1991, Pseudotyping with human T-cell leukemia virus type 1 broadens the human immunodeficiency virus host range, J. Virol., 65, 162, 10.1128/JVI.65.1.162-169.1991

Leonard, 1990, Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells, J. Biol. Chem., 265, 10373, 10.1016/S0021-9258(18)86956-3

Li, 1991, Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue, J. Virol., 65, 3973, 10.1128/JVI.65.8.3973-3985.1991

Lifson, 1986, Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein, Science, 323, 725

Linsley, 1988, Effects of anti-gp120 monoclonal antibodies on CD4 receptor binding by the env protein of human immunodeficiency virus type 1, J. Virol., 62, 3695, 10.1128/JVI.62.10.3695-3702.1988

Loetscher, 1994, Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes, J. Biol. Chem., 269, 232, 10.1016/S0021-9258(17)42339-8

Maddon, 1986, The T4 gene encodes the AIDS receptor and is expressed in the immune system and the brain, Cell, 47, 333, 10.1016/0092-8674(86)90590-8

Mascola, 1994, Two antigenically distinct subtypes of human immunodeficiency virus type 1, J. Infect. Dis., 169, 48, 10.1093/infdis/169.1.48

McDougal, 1986, Binding of the HTLV-III/LAV to T4+ T cells by a complex of the 100K viral protein and the T4 molecule, Science, 231, 382, 10.1126/science.3001934

McKnight, 1994, HIV-2 and SIV infection of nonprimate cell lines expressing human CD4, Virology, 201, 8, 10.1006/viro.1994.1260

Montefiori, 1991, Homotypic antibody responses to fresh clinical isolates of human immunodeficiency virus, Virology, 182, 635, 10.1016/0042-6822(91)90604-A

Moore, 1994, Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies, J. Virol., 68, 469, 10.1128/JVI.68.1.469-484.1994

Moore, 1995, Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120, J. Virol., 69, 101, 10.1128/JVI.69.1.101-109.1995

Myers, 1994

Neote, 1993, Molecular cloning, functional expression, and signalling characteristics of a C-C chemokine receptor, Cell, 72, 415, 10.1016/0092-8674(93)90118-A

O'Brien, 1990, HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain, Nature (London), 348, 69, 10.1038/348069a0

Page, 1992, Analysis of mutations in the V3 domain of gp160 that affect fusion and infectivity, J. Virol., 66, 524, 10.1128/JVI.66.1.524-533.1992

Palermo, 1991, Production of analytical quantities of recombinant proteins in Chinese hamster ovary cells using sodium butyrate to elevate gene expression, J. Biotech., 19, 35, 10.1016/0168-1656(91)90073-5

Paxton, 1996, Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures, Nature Med., 2, 412, 10.1038/nm0496-412

Peden, 1991, Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI, Virology, 185, 661, 10.1016/0042-6822(91)90537-L

Ponath, 1996, Cloning of the human eosinophil chemoattractant, eotaxin, J. Clin. Invest., 97, 604, 10.1172/JCI118456

Ponath, 1996, Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils, J. Exp. Med., 183, 1, 10.1084/jem.183.6.2437

Pope, 1994, Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1, Cell, 78, 389, 10.1016/0092-8674(94)90418-9

Power, 1995, Molecular cloning and functional expression of a novel CC chemokine receptor cDNA from a human basophilic cell line, J. Biol. Chem., 270, 19495, 10.1074/jbc.270.33.19495

Probst, 1992, Sequence alignment of the G protein–coupled receptor superfamily, DNA Cell Biol., 11, 1, 10.1089/dna.1992.11.1

Putney, 1986, HTLV-III/LAV-neutralizing antibodies to the E. coli produced fragment of the virus envelope, Science, 234, 1392, 10.1126/science.2431482

Raport, 1996, Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1β, and MIP-1α, J. Biol. Chem., in press., 10.1074/jbc.271.29.17161

Rusche, 1988, Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino-acid sequence of the viral envelope gp120, Proc. Natl. Acad. Sci. USA, 85, 3198, 10.1073/pnas.85.9.3198

Samson, 1996, Molecular cloning and functional expression of a new human CC-chemokine receptor gene, Biochemistry, 35, 3362, 10.1021/bi952950g

Schall, 1994, Chemokines, leukocyte trafficking, and inflammation, Curr. Opin. Immunol., 6, 865, 10.1016/0952-7915(94)90006-X

Schuitemaker, 1991, Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable at all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture, J. Virol., 65, 356, 10.1128/JVI.65.1.356-363.1991

Schuitemaker, 1992, Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection, J. Virol., 65, 356, 10.1128/JVI.65.1.356-363.1991

Skinner, 1988, Characteristics of a neutralizing monoclonal antibody to the HIV envelope glycoprotein, AIDS Res. Hum. Retrovir., 4, 187, 10.1089/aid.1988.4.187

Sodroski, 1986, Role of the HTLV-III envelope in syncytium formation and cytopathicity, Nature, 321, 412, 10.1038/321412a0

Sozzani, 1995, Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines, J. Immunol., 155, 3292, 10.4049/jimmunol.155.7.3292

Spira, 1996, Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques, J. Exp. Med., 183, 215, 10.1084/jem.183.1.215

Stein, 1987, pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane, Cell, 49, 659, 10.1016/0092-8674(87)90542-3

Sullivan, 1995, Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T cell line–passaged human immunodeficiency virus type 1 isolates, J. Virol., 69, 4413, 10.1128/JVI.69.7.4413-4422.1995

Tersmette, 1988, Differential syncytium-inducing capacity of human immunodeficiency virus isolates, J. Virol., 62, 2026, 10.1128/JVI.62.6.2026-2032.1988

Thali, 1994, Functional association of cyclophilin A with HIV-1 virions, Nature, 372, 363, 10.1038/372363a0

Travis, 1992, Functional roles of the V3 hypervariable region of HIV-1 gp160 in the processing of gp160 and in the formation of syncytia in CD4+ cells, Virology, 186, 313, 10.1016/0042-6822(92)90088-7

Valentin, 1994, Dual tropism for macrophages and lymphocytes is a common feature of primary human immunodeficiency virus type 1 and 2 isolates, J. Virol., 68, 6684, 10.1128/JVI.68.10.6684-6689.1994

von Zastrow, 1992, Ligand-regulated internalization and recycling of human β2-adrenergic receptors between the plasma membrane and endosomes containing transferrin receptors, J. Biol. Chem., 267, 3530, 10.1016/S0021-9258(19)50762-1

Weissman, 1995, Three populations of cells with dendritic morphology exist in peripheral blood only one of which is infectible with human immunodeficiency virus type 1, Proc. Natl. Acad. Sci. USA, 92, 826, 10.1073/pnas.92.3.826

Weller, 1995, Infection, apoptosis and killing of mature human eosinophils by human immunodeficiency virus−1, Am. J. Respir. Cell Mol. Biol., 10, 610, 10.1165/ajrcmb.13.5.7576698

Westervelt, 1991, Identification of a determinant within the human immunodeficiency virus surface envelope glycoprotein critical for productive infection of primary monocytes, Proc. Natl. Acad. Sci. USA, 88, 3097, 10.1073/pnas.88.8.3097

Westervelt, 1992, Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo, J. Virol., 66, 2577, 10.1128/JVI.66.4.2577-2582.1992

Willey, 1994, Amino acid substitutions in the human immunodeficiency virus type 1 gp120 V3 loop that change viral tropism also alter physical and functional properties of the virion envelope, J. Virol., 68, 4409, 10.1128/JVI.68.7.4409-4419.1994

Wrin, 1995, Adaptation to persistent growth in the H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine sera, J. Virol., 69, 39, 10.1128/JVI.69.1.39-48.1995